261 related articles for article (PubMed ID: 29074329)
1. Degree of ketonaemia and its association with insulin resistance after dapagliflozin treatment in type 2 diabetes.
Min SH; Oh TJ; Baek SI; Lee DH; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
Diabetes Metab; 2018 Feb; 44(1):73-76. PubMed ID: 29074329
[TBL] [Abstract][Full Text] [Related]
2. Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
Yeo SM; Park H; Paek JH; Park WY; Han S; Park SB; Jin K
Medicine (Baltimore); 2019 Jan; 98(3):e14150. PubMed ID: 30653152
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes.
Herring RA; Shojaee-Moradie F; Garesse R; Stevenage M; Jackson N; Fielding BA; Mendis A; Johnsen S; Umpleby AM; Davies M; Russell-Jones DL
Diabetes Care; 2020 Sep; 43(9):2128-2136. PubMed ID: 32641376
[TBL] [Abstract][Full Text] [Related]
4. Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.
Pfützner A; Klonoff D; Heinemann L; Ejskjaer N; Pickup J
Endocrine; 2017 Apr; 56(1):212-216. PubMed ID: 28303514
[TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin: a new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes.
Vivian EM
Am J Health Syst Pharm; 2015 Mar; 72(5):361-72. PubMed ID: 25694411
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin-treated T2DM patients: Results from the Qatar Study.
Abdul-Ghani M; Migahid O; Megahed A; Singh R; Fawaz M; DeFronzo RA; Jayyousi A
Diabetes Obes Metab; 2019 Mar; 21(3):705-709. PubMed ID: 30259621
[TBL] [Abstract][Full Text] [Related]
7. [Euglycemic ketosis in an adolescent with type 1 diabetes on insulin and dapaglifozin: Case report].
Pereyra A M; Ramírez C; Román R
Rev Chil Pediatr; 2017 Jun; 88(3):404-410. PubMed ID: 28737202
[TBL] [Abstract][Full Text] [Related]
8. Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
Ferrannini E; Baldi S; Frascerra S; Astiarraga B; Heise T; Bizzotto R; Mari A; Pieber TR; Muscelli E
Diabetes; 2016 May; 65(5):1190-5. PubMed ID: 26861783
[TBL] [Abstract][Full Text] [Related]
9. The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis.
Wallenius K; Kroon T; Hagstedt T; Löfgren L; Sörhede-Winzell M; Boucher J; Lindén D; Oakes ND
J Lipid Res; 2022 Mar; 63(3):100176. PubMed ID: 35120993
[TBL] [Abstract][Full Text] [Related]
10. The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients.
Latva-Rasku A; Honka MJ; Kullberg J; Mononen N; Lehtimäki T; Saltevo J; Kirjavainen AK; Saunavaara V; Iozzo P; Johansson L; Oscarsson J; Hannukainen JC; Nuutila P
Diabetes Care; 2019 May; 42(5):931-937. PubMed ID: 30885955
[TBL] [Abstract][Full Text] [Related]
11. [Life-threatening ketoacidosis in a 25-year-old woman treated with sodium-glucose cotransporter 2 inhibitor].
Lindberg MJ; Kristensen FB; Yildiz A
Ugeskr Laeger; 2016 Nov; 178(47):. PubMed ID: 27908315
[TBL] [Abstract][Full Text] [Related]
12. Dapagliflozin: A Sodium Glucose Cotransporter 2 Inhibitor for the Treatment of Diabetes Mellitus.
Davis PN; Ndefo UA; Oliver A
J Pharm Pract; 2016 Apr; 29(2):165-71. PubMed ID: 25609661
[TBL] [Abstract][Full Text] [Related]
13. Dapagliflozin, an SGLT2 inhibitor for the treatment of type 2 diabetes.
Demaris KM; White JR
Drugs Today (Barc); 2013 May; 49(5):289-301. PubMed ID: 23724409
[TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study.
Henry RR; Dandona P; Pettus J; Mudaliar S; Xu J; Hansen L
Diabetes Obes Metab; 2017 Jun; 19(6):814-821. PubMed ID: 28098426
[TBL] [Abstract][Full Text] [Related]
15. Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study.
Tang Y; Sun Q; Bai XY; Zhou YF; Zhou QL; Zhang M
Nutr Diabetes; 2019 Nov; 9(1):32. PubMed ID: 31685792
[TBL] [Abstract][Full Text] [Related]
16. Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes.
Daniele G; Xiong J; Solis-Herrera C; Merovci A; Eldor R; Tripathy D; DeFronzo RA; Norton L; Abdul-Ghani M
Diabetes Care; 2016 Nov; 39(11):2036-2041. PubMed ID: 27561923
[TBL] [Abstract][Full Text] [Related]
17. Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study.
Biester T; Muller I; von dem Berge T; Atlas E; Nimri R; Phillip M; Battelino T; Bratina N; Dovc K; Scheerer MF; Kordonouri O; Danne T
Diabetes Obes Metab; 2021 Feb; 23(2):599-608. PubMed ID: 33217117
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes.
Kuhadiya ND; Ghanim H; Mehta A; Garg M; Khan S; Hejna J; Torre B; Makdissi A; Chaudhuri A; Batra M; Dandona P
J Clin Endocrinol Metab; 2016 Sep; 101(9):3506-15. PubMed ID: 27490915
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin-Associated Diabetic Ketoacidosis.
Chakinala RC; Chang AP; Solanki S; Haq KF; Cho R
Am J Ther; 2018; 25(6):e765-e766. PubMed ID: 29672334
[No Abstract] [Full Text] [Related]
20. Clinical risk factors predicting genital fungal infections with sodium-glucose cotransporter 2 inhibitor treatment: The ABCD nationwide dapagliflozin audit.
Thong KY; Yadagiri M; Barnes DJ; Morris DS; Chowdhury TA; Chuah LL; Robinson AM; Bain SC; Adamson KA; Ryder REJ;
Prim Care Diabetes; 2018 Feb; 12(1):45-50. PubMed ID: 28669625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
